Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A cohort study was undertaken of 18 consecutive pregnancies in 16 patients with
systemic lupus erythematosus
without significant renal impairment. Of these, eight each had at least two previously unexplained pregnancy failures, 10 had elevated anticardiolipin antibodies, nine had the
lupus
anticoagulant and five had antibodies to Ro. Twelve live births resulted but a
Downs syndrome
baby died in the perinatal period. Fetal morbidity was confined to four cases of fetal growth retardation, all in mothers positive for anticardiolipin antibodies, and fetal distress in another two. There were no cases of the neonatal
lupus
syndrome. There was one maternal death. An obstetric history of at least two previously unexplained pregnancy failures and the presence of maternal anticardiolipin or anti-Ro antibodies accurately predicted fetal loss in six of seven cases. No other serological risk factors for fetal loss were identified. We were unable to show that suppression of antibodies in those mothers with at least two previously unexplained pregnancy failures improved fetal outcome.
...
PMID:Pregnancy and lupus: prognostic indicators and response to treatment. 317 25
Anti-IgG antibodies were detected in 69% of 235 sera tested. A simple and reproducible method was developed to measure the avidity index of anti-IgG antibodies. It was found that subjects with
systemic lupus erythematosus
and progressive systemic sclerosis and normal controls had antibodies with lower avidity index than those with rheumatoid arthritis and
Down's syndrome
. The difference in avidity seems to be disease specific. Avidity does not correlate with antibody titers, but all sera with high avidity antibody are positive in the latex test. The anti-IgG as measured by this method was shown to be mainly of IgM class. The avidity indices of whole sera and purified IgM fractions were similar.
...
PMID:Avidity indices of anti-IgG antibodies in diseases. 645 18
The clinical, hematologic, and cytogenetic findings are described in a patient who developed clinical and hematologic features of acute myelogenous leukemia (AML) after a three-year period of observation with unexplained thrombocytopenia. Five months before the diagnosis of AML she developed hepatosplenomegaly and a
lupus
-like syndrome. At this time she was also found to have
trisomy 21
in all bone marrow cells studied, in addition to trisomy 8 in a few cells. The finding of
trisomy 21
in all of the bone marrow cells examined could reflect a nonrandom alteration in the leukemic stem line or it might indicate that mosaic patients with
trisomy 21
cells in their bone marrow share the increased risk of AML that has been documented for
trisomy 21
patients.
...
PMID:Trisomy 21 in bone marrow cells of a patient with a prolonged preleukemic phase. 693 5
An 8-year-old male, who had
Down syndrome
associated with
systemic lupus erythematosus
(
SLE
), is described. He also had a partial complement 4 deficiency. This case is a reminder that the physician should be aware of the possibility of an immune defect in a male presenting with
SLE
at a young age. The question of whether the association of
Down syndrome
with
SLE
is coincidental or whether there is a predilection for autoimmune disorders in
Down syndrome
is discussed.
...
PMID:Down syndrome associated with systemic lupus erythematosus: a mere coincidence or a significant association? 783 1
Moyamoya disease is characterized by bilateral involvement of the internal carotid arteries. The etiology of this involvement is unknown. However, we previously reported two pediatric cases of moyamoya disease that progressed from unilateral to bilateral involvement. Some cases of unilateral occlusion in the carotid fork seem to have occurred at an early stage of definite moyamoya disease. In the present study, we examined five pediatric patients showing bilateral and/or unilateral occlusion of the internal carotid artery. In each case, the etiology was known. They included Apert syndrome, radiation therapy for pilocytic astrocytoma, systemic
lupus
erythematosis, von Recklinghausen disease and
Down syndrome
. The clinical manifestations, EEG, CT, MRI, PET, and angiographic findings in these patients were presented in comparison with those of definite moyamoya disease. This comparison led us to suggest that definite moyamoya disease might be included in these cases, and we emphasize the importance of precise examination in each case.
...
PMID:[Akin moyamoya disease in children]. 842 89
An association is described between women with
lupus
anticoagulant and abnormal prenatal serum screening results. Three cases of positive second-trimester serum screening for
Down syndrome
, with karyotypically normal fetuses, in women demonstrated to have
lupus
anticoagulant are presented. Serum screening positivity was principally due to a disproportionately elevated maternal serum human chorionic gonadotrophin (hCG) level. In each case, early, severe intrauterine growth restriction was documented, with only one fetus surviving the neonatal period. As maternal
lupus
anticoagulant may have a profoundly adverse effect on the course of pregnancy, we suggest that an elevated hCG level on prenatal screening prompt consideration of maternal
lupus
anticoagulant testing if ultrasonography demonstrates an otherwise normal singleton gestation and the fetal karyotype is normal.
...
PMID:Elevated mid-trimester hCG and maternal lupus anticoagulant. 860 82
Our study describes the presence of antineutrophil cytoplasmic antibodies (ANCA) in a group of different pathologies comprising 101 patients. Rheumatoid arthritis, systemic
lupus
erithematosus, idiopatic neutropenia, acute post-streptoccocal glomerulonephritis, minimal change nephrotic syndrome,
Downs syndrome
, adult periodontitis, tumoral calcinosis, monoartheritis and lipodystrophy were investigated for ANCA, through indirect immunofluorescence and an indirect solid-phase immunoassay (ELISA). Our results show the pattern of distribution of ANCA in the diseases investigated, and allowed us to make the first description of ANCA in diseases such as
Downs syndrome
, acute post-streptococcal glomerulonephritis and adult periodontitis. The high percentage of reactivity for ANCA detected in adult periodontitis, raise important questions about the possibility of reporting inaccurate percentages of positivity for some diseases, due to the presence of a concurrent disease such as adult periodontitis.
...
PMID:[Antineutrophil cytoplasmic antibodies (ANCA): study of their presence in diseases not associated with arteritis]. 871 20
Elastosis perforans serpiginosa can arise as a rare complication in patients with
Down syndrome
. It is one of the primary perforating disorders characterized by transepithelial elimination of abnormal elastic fibers. This may reflect an immunological reaction aquist elastic fibers. We describe a 40-year-old woman with
Down's syndrome
whose skin lesions were histologically mistaken for
lupus
vulgaris for a long time.
...
PMID:[Elastosis perforans serpiginosa in Down syndrome]. 948 66
Maternal serum inhibin A levels are increased on average in pregnancies affected by
Down syndrome
(DS). However, some reports have found increased serum levels in women with pre-eclamptic toxaemia as well. In the current study, maternal serum inhibin A was retrospectively measured in a series of 32 serum samples from pregnant women previously diagnosed as having either
systemic lupus erythematosus
(
SLE
) or primary antiphospholipid syndrome (APS). For comparison, normal medians were calculated from 57 unaffected control pregnancies together with a total of 854 samples tested at 13-19 weeks of gestation as part of the routine antenatal DS screening. All results were expressed in multiples of the gestation specific normal medians (MoM). A cubic regression formula was fitted, weighting for the number of women tested at each gestation. The median MoM value in the 16 cases of
SLE
and the 16 cases of primary APS is 0.60 (95% confidence interval 0.40-0.91) and 0.88 (95% confidence interval 0.66-1.17), respectively. For primary APS this was not statistically significant, whereas the
SLE
patients had a highly statistically significant reduction of serum inhibin A (p<0.002, Wilcoxon Rank sum Test, 2 tailed). Six pregnancies in the
SLE
group had a complicated obstetric outcome, i.e. missed abortion, placental abruption, exacerbation of the underlying disease which necessitated delivery, and severe postpartum haemorrhage. In 85% of this subgroup, serum inhibin A levels were below the normal 10th centile. The current data suggest that serum inhibin A is decreased on average in
SLE
patients. Those preliminary results might have various obstetric implications such as antenatal DS screening of
SLE
patients, identification of pregnant women at risk of developing
SLE
, who have presented for routine DS screening and for monitoring
SLE
patients throughout their pregnancy.
...
PMID:Serum inhibin A levels in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome. 1070 44
Maternal serum human chorionic gonadotrophin (hCG) levels were measured during the second and the third trimesters of pregnancy in patients with either
systemic lupus erythematosus
(
SLE
) or primary antiphospholipid syndrome (APS). All results were expressed in multiples of the gestation-specific normal medians (MoM). The median MoM level in 17 samples from
SLE
patients was 1.48 compared with 0.79 MoM in 99 controls of similar gestation (p < 0.002, Wilcoxon Rank sum test). In contrast the median MoM level in 19 samples from primary APS patients was only 1.14. These preliminary findings should be further studied to evaluate the implications for
Down syndrome
screening, detection of
SLE
cases during pregnancy and the prediction of adverse outcome in
SLE
gestations.
...
PMID:Maternal serum human chorionic gonadotrophin levels in systemic lupus erythematosus and antiphospholipid syndrome. 1124 44
1
2
Next >>